Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Georgia
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in Georgia
3 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in Georgia.
Cities in Georgia
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT04301076A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Children's Hospital of Atlanta, Atlanta
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794A Registry for People With T-cell Lymphoma
- Emory University (Data Collection Only), Atlanta
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.